Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Open Label Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PHIN-214 in Adults With Child Pugh A and B Cirrhosis

NCT05490888 is registered in ClinicalTrials.gov with PharmaIN as lead sponsor.

NCT NCT05490888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05490888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Open Label Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PHIN-214 in Adults With Child Pugh A and B Cirrhosis
Lead sponsor
PharmaIN
Phase
Phase 1
Overall status
Recruiting
Start date
January 3, 2022
Completion date
June 30, 2026
Enrollment
74 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ascites hepatic, cirrhosis, liver, liver fibrosis